Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.
Salarinia R, Sahebkar A, Peyvandi M, Mirzaei HR, Jaafari MR, Riahi MM, Ebrahimnejad H, Nahand JS, Hadjati J, Asrami MO, Fadaei S, Salehi R, Mirzaei H. Salarinia R, et al. Among authors: hadjati j. Curr Cancer Drug Targets. 2016;16(9):773-788. doi: 10.2174/1568009616666151207110143. Curr Cancer Drug Targets. 2016. PMID: 26638884 Review.
Low Noncytotoxic Concentrations of 5-Fluorouracil Have No Adverse Effects on Maturation and Function of Bone Marrow-Derived Dendritic Cells in vitro: A Potentially Safe Adjuvant for Dendritic Cell-Based Cancer Therapy.
Namdar A, Mirzaei HR, Hafezi M, Khosravianfar N, Kheshtchin N, Mirzaei R, Hadjati J, Rezaei A. Namdar A, et al. Among authors: hadjati j. Int Arch Allergy Immunol. 2015;168(2):122-30. doi: 10.1159/000442290. Epub 2015 Dec 18. Int Arch Allergy Immunol. 2015. PMID: 26678791 Free article.
PiggyBac as a novel vector in cancer gene therapy: current perspective.
Mirzaei H, Sahebkar A, Jaafari MR, Hadjati J, Javanmard SH, Mirzaei HR, Salehi R. Mirzaei H, et al. Among authors: hadjati j. Cancer Gene Ther. 2016 Feb-Mar;23(2-3):45-7. doi: 10.1038/cgt.2015.68. Epub 2016 Jan 8. Cancer Gene Ther. 2016. PMID: 26742580
Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model.
Namdar A, Mirzaei R, Memarnejadian A, Boghosian R, Samadi M, Mirzaei HR, Farajifard H, Zavar M, Azadmanesh K, Elahi S, Noorbakhsh F, Rezaei A, Hadjati J. Namdar A, et al. Among authors: hadjati j. Cancer Immunol Immunother. 2018 Mar;67(3):367-379. doi: 10.1007/s00262-017-2088-6. Epub 2017 Nov 9. Cancer Immunol Immunother. 2018. PMID: 29124314 Free PMC article.
95 results